AAP maintains routine vaccine recs despite CDC changes; FDA warns of serious injury with wound and burn products; subcutaneous Alzheimer disease treatment under review; Cardamyst nasal spray available ...
Topline results show eDSP failed to significantly improve RmICARS scores in ataxia-telangiectasia patients compared with placebo in the NEAT trial.
The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation of arsenic trioxide, for the treatment of acute promyelocytic leukemia (APL), an aggressive ...
HealthDay News — Individuals with hypertension are unlikely to measure their blood pressure (BP) at home as often as ...
No increased risk for death, acute neurosurgical operations, or length of hospitalization seen in association with ...
The researchers found that patients taking GLP-1 RAs had a significantly reduced incidence of revision FESS versus the non-GLP-1 RA group at one-year (risk ratio [RR], 0.64) and five-year follow-up ...
HealthDay News — Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of ...
HealthDay News — A fast-growing measles outbreak in South Carolina has eclipsed last year’s record-setting Texas surge. As of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results